89 related articles for article (PubMed ID: 6131985)
1. 5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors.
Maj J; Rogóz Z; Skuza G
J Pharm Pharmacol; 1983 Feb; 35(2):128-9. PubMed ID: 6131985
[No Abstract] [Full Text] [Related]
2. The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1983; 35(1):49-57. PubMed ID: 6604264
[TBL] [Abstract][Full Text] [Related]
3. Biochemical pharmacology of the serotonin system.
Fuller RW
Adv Neurol; 1986; 43():469-80. PubMed ID: 2936068
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of serotonin uptake inhibitors in depression.
Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
[TBL] [Abstract][Full Text] [Related]
5. Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration.
Durcan MJ; Lister RG; Eckardt MJ; Linnoila M
Psychopharmacology (Berl); 1988; 96(4):528-33. PubMed ID: 3149776
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
Wong DT; Bymaster FP; Reid LR; Threlkeld PG
Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
[TBL] [Abstract][Full Text] [Related]
7. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
Claassen V; Davies JE; Hertting G; Placheta P
Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in-vivo: the effects of desipramine, maprotiline, femoxetine and citalopram.
Pawłowski L; Nowak G
J Pharm Pharmacol; 1987 Dec; 39(12):1003-9. PubMed ID: 2894425
[TBL] [Abstract][Full Text] [Related]
9. Norzimelidine, a metabolite of a highly selective 5-hydroxytryptamine uptake inhibitor, can inhibit the uptake of noradrenaline in-vivo.
Pawłowski L; Mazela H
J Pharm Pharmacol; 1984 Dec; 36(12):855-8. PubMed ID: 6151986
[TBL] [Abstract][Full Text] [Related]
10. Reduction of voluntary morphine consumption following treatment with zimelidine.
Rockman GE; Amit Z; Bourque C; Brown ZW; Ogren SO
Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):123-9. PubMed ID: 6448029
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
Njung'e K; Handley SL
Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of fluoxetine and zimelidine on the uptake of 5-hydroxytryptamine and tryptamine by cortical slices and on responses of cortical neurones to stimulation of the nucleus raphe medianus.
Jones RS; Broadbent J
Eur J Pharmacol; 1982 Jul; 81(4):681-5. PubMed ID: 6214414
[TBL] [Abstract][Full Text] [Related]
13. Effect of a specific 5HT uptake inhibitor (citalopram) on drug accumulation by rat lung slices.
Drew R; Siddik ZH
Pharmacology; 1980; 20(1):27-31. PubMed ID: 6929555
[TBL] [Abstract][Full Text] [Related]
14. 5-HT uptake inhibitors: psychopharmacological and neurobiochemical criteria of selectivity.
Maître L; Baumann PA; Jackel J; Waldmeier PC
Adv Biochem Psychopharmacol; 1982; 34():229-46. PubMed ID: 6215834
[No Abstract] [Full Text] [Related]
15. The antidepressant agents desipramine, fluoxetine, fluvoxamine and norzimelidine inhibit uptake of [3H]noradrenaline and [3H]5-hydroxytryptamine in slices of human and rat cortical brain tissue.
Harms HH
Brain Res; 1983 Sep; 275(1):99-104. PubMed ID: 6226337
[TBL] [Abstract][Full Text] [Related]
16. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities.
Pawlowski L; Nowak G; Górka Z; Mazela H
Psychopharmacology (Berl); 1985; 86(1-2):156-63. PubMed ID: 3927352
[TBL] [Abstract][Full Text] [Related]
17. Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety.
Durcan MJ; Lister RG; Eckardt MJ; Linnoila M
Adv Alcohol Subst Abuse; 1988; 7(3-4):113-7. PubMed ID: 3146920
[TBL] [Abstract][Full Text] [Related]
18. Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats.
Jobe PC; Ray TB
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):185-8. PubMed ID: 6968962
[TBL] [Abstract][Full Text] [Related]
19. Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves.
Adler-Graschinsky E; Butta NV; Elgoyhen AB
Life Sci; 1986 Jul; 39(1):61-8. PubMed ID: 3487690
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat.
Blier P; De Montigny C
J Neurosci; 1983 Jun; 3(6):1270-8. PubMed ID: 6304261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
